MARK AUGUSTINE is a Senior Research Analyst with U.S. Bancorp Piper
Jaffray’s Equity Research Group, where he focuses on biotechnology
companies. He was most recently a Biotechnology Analyst and a Vice
President in the Equity Research Department at SG Cowen Securities. He
previously worked at Morgan Stanley & Co. and Canaan Partners, a venture
capital firm. Mr. Augustine graduated Magna Cum Laude from Yale College
and received his MBA from Harvard University.